Ma, Jennifer S Y <br/><br/>
Versatile strategy for controlling the specificity and activity of engineered T cells.  [electronic resource] 

 -  Proceedings of the National Academy of Sciences of the United States of America  Jan 2016 
 - E450-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1091-6490 
<br/><br/><label>Standard No.: </label>10.1073/pnas.1524193113  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antigens, CD19--immunology<br/>Antigens, Neoplasm--immunology<br/>Azides<br/>B-Lymphocytes--immunology<br/>Cell Line, Tumor<br/>Cytotoxicity, Immunologic<br/>Female<br/>Fluorescein-5-isothiocyanate<br/>Genetic Vectors<br/>Humans<br/>Immunotherapy, Adoptive--adverse effects<br/>Lentivirus--genetics<br/>Leukemia, B-Cell--therapy<br/>Lymphocyte Activation<br/>Lymphopenia--etiology<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Inbred NOD<br/>Mice, SCID<br/>Models, Molecular<br/>Phenylalanine--analogs & derivatives<br/>Protein Conformation<br/>Protein Engineering--methods<br/>Receptors, Antigen, T-Cell--genetics<br/>Recombinant Fusion Proteins--immunology<br/>Sialic Acid Binding Ig-like Lectin 2--immunology<br/>Single-Chain Antibodies--genetics<br/>T-Cell Antigen Receptor Specificity<br/>T-Lymphocytes--immunology<br/>Transduction, Genetic<br/>Xenograft Model Antitumor Assays